Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Post by BearDownAZon Sep 10, 2015 12:23pm
170 Views
Post# 24092888

Does PoC have a good side?

Does PoC have a good side?I have no desire or care to be on your good side PoC. The fact that you react to my post the way you do speaks of your character. I have no more info, background or opinion on the FDA issue to add here. As to chronic care or life threatening unmet need......diabetes/cardiovascular disease are chronic diseases and they are life threatening, so why not both? 

BDAZ

PoC wrote:

"hey bearskin, if you want to get back in my good book, here is a challenge for you (which BTW will help all owners)...WTF is up with the non-FDA thingy, it is very quizzical...here are my thoughts:
 
a) is BoM diabetes or cholesterol??? and what difference does that make in FDA world???
 
b) is BoM chronic care or life threatening unmet need??? that makes a big difference IMO
 
c) ????
 
and i say this as best i can tell the trial design seems pretty SOP by FDA standards..event based, adaptive, long duration, etc.
 
ps still like to see 208 as mono but hey there you go"
Read more at https://www.stockhouse.com/companies/bullboard/t.rvx/resverlogix-corp#QFgvfkUpXMy0OpI0.99


 
Bullboard Posts